AF
IDYA icon

Amalgamated Financial’s IDEAYA Biosciences IDYA Stock Holding History

Amalgamated Financial’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$48K Buy
+4,278
New +$63.1K ﹤0.01% 2454

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Amalgamated Financial's IDYA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in IDEAYA Biosciences (IDYA) in Q1 2022: 4,278 shares worth $48K. The stake represents ﹤0.01% of the portfolio and ranks #2454 among its holdings.

103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Amalgamated Financial held 4,278 shares of IDEAYA Biosciences worth $48K as of Q1 2022.
  • IDEAYA Biosciences was a new Amalgamated Financial position in Q1 2022.
  • IDEAYA Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2454 holding.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.